Mazdutide (also known as IBI362 or LY3305677) is an investigational drug, currently in clinical trials, primarily for the treatment of obesity and type 2 diabetes.
It is a novel type of therapeutic agent known as a dual agonist.
Read More DetailsThe information, including but not limited to, text, graphics, images and other material contained on this website are for informational purposes only. No material on this site is intended to be a substitute for the consultation, diagnosis, and/or medical treatment of a qualified physician or healthcare provider.